Zimmer and Stryker, which mostly build knee and hip devices, may be under pressure to buy smaller orthopedic companies in faster-growing parts of the industry, said David Turkaly, an analyst at Susquehanna Financial Group. Likely targets include ArthroCare, BioMimetic Therapeutics, Wright Medical Group and Mako Surgical, he said.
“What clearly happens is J&J becomes No. 1 in all of ortho,” Mr. Turkaly said. “The Strykers and Zimmers of the world are probably now a good distance behind the animal that J&J is in those markets.”
Read the Bloomberg report on orthopedics device companies.
Related Articles on the Orthopedic and Spine Market:
Johnson & Johnson to Acquire Synthes for $21.3B
Millennium Research Group: Orthopedic Extremities Market to Generate $4.6B by 2015
6 Predictions on Device Market Growth in the Next Five Years
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
